Impact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder

Substance Use &amp Addiction Journal, Journal Year: 2024, Volume and Issue: unknown

Published: June 3, 2024

Background: Medications for opioid use disorders (MOUDs) are effective, but most people with disorder (OUD) do not receive treatment. Prior research has explored patients’ structural barriers to access and perceptions of MOUD. Little considered treatment knowledge outside the patient population. Members public without OUD themselves (eg, family, friends) can significantly influence decisions persons OUD. Considering these gaps, we conducted an original survey a diverse sample US adults explore preferences toward treatments. Methods: We online 1505 White, Black, Latino/a Americans including small percentage (8.5%) self-reported lifetime The used vignettes describe hypothetical patients OUD, provide basic information (ie, methadone, buprenorphine, naltrexone, nonmedication treatment), then assessed preferences. Using multivariable logistic regression, examined associations between covariates interest perceived access, knowledge, demographics) preference MOUD versus Results: There were 523 502 480 respondents. Across racial/ethnic subsamples, respondents had greatest treatments, Black (72.7%) (70.2%) having greater compared White (61.8%). However, after viewing vignette, proportion chose methadone (35.8%) or buprenorphine (34.8%) as their first-choice patients. Multivariable regression suggested that among respondents, those more likely choose than (odds ratio = 2.41, 95% confidence interval 1.34-4.34). Perceived did affect choice. Conclusions: racial groups, was MOUD, many still selected Significant findings emphasized importance around decision-making, highlighting opportunities tailored education efforts improve uptake evidence-based

Language: Английский

---

Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey

Addiction Science & Clinical Practice, Journal Year: 2022, Volume and Issue: 17(1)

Published: Nov. 18, 2022

Abstract Background Despite the proven efficacy of medications for opioid use disorder (MOUD) and recent reduction in barriers to prescribers, numerous obstacles exist patients seeking MOUD. Prior studies have used telephone surveys investigate pharmacy-related We applied this methodology evaluate inpatient outpatient pharmacy MOUD South Florida. Methods Randomly selected pharmacies Florida (Miami-Dade, Broward, Palm Beach Counties) were called using a standardized script with “secret shopper” approach until 200 successful had been completed. The primary outcome was availability any buprenorphine products. Second, list all 48 acute care hospitals within aforementioned counties compiled, contacted by second structured script. Results A total 1374 identified. 378 randomly accrue calls (53% success rate). All successfully complete 25 (52%). Of contacted, 38% available. There significant difference county, Miami-Dade having least most (27% vs. 47%, respectively; p = 0.04). available, 82% sufficient supply two-week prescription 8 mg twice daily. that did not buprenorphine, 55% would be willing order median estimated time receive an 2 days (IQR 1.25–3 days). surveyed pharmacies, 88% reported on formulary, at one restriction ordering beyond federal regulations. Conclusions results study highlight comprehensive OUD treatment across healthcare system including both hospital community pharmacies. efforts increase number providers, there still remain downstream access.

Language: Английский

---

Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder

Journal of Addiction Medicine, Journal Year: 2023, Volume and Issue: 17(4), P. e224 - e231

Published: Jan. 6, 2023

The aims of the study are to evaluate community pharmacists' knowledge and perceptions regarding buprenorphine for opioid use disorder their willingness dispense identify opportunities education.An electronic survey Michigan pharmacists (n = 11,123) assessed demographics, training, knowledge, dispensing, stigma, diversion, confidence in patient/provider interactions. Composite scores were calculated. Cross-tabulations logistic regressions examined associations.There 775 surveys returned (response 7%, n with 390 completing survey. Twenty-five percent practiced a rural area. Common practice sites chain or independent pharmacies (30% each). Ninety-seven had 50% from Accredited Continuing Pharmacy Education. Eighty reported that pharmacy dispensed 90% compared 71% urban responding yes. did not differ between location (P > 0.05). Predictors (odds ratio, OR, 0.55; 95% interval [CI], 0.34-0.91; P 0.01), (OR, 0.53; CI, 0.30-0.94; 0.03), Education training 0.54; 0.34-0.87; low stigma/diversion 0.51; 0.37-0.70; 0.00), interactions 0.14; 0.10-0.19; 0.00).Most at disorder, larger proportion reporting availability. Pharmacists locations have increased buprenorphine, having lower diversion rural. Differences availability, pharmacist dispense, education. Limitations include one state, response bias, self-assessed competencies, small samples.

Language: Английский

---

Assessing suboxone access in community pharmacies: Secret shopper model

Exploratory Research in Clinical and Social Pharmacy, Journal Year: 2023, Volume and Issue: 12, P. 100356 - 100356

Published: Nov. 3, 2023

To assess whether Maryland community pharmacies had Suboxone available for dispensing.This cross-sectional study used a secret shopper model to contact public-facing in Maryland. The shopper, guided by script, asked prescription was the same or next day pick-up. A small convenience sample of who did not have received an in-person visit inquire about medication availability and dispensing barriers.After contacting 99% (n = 1046) pharmacies, confirmed immediate pick-up 31% 326). remaining have, would disclose, limited access (existing patients specific providers only). Significant differences were found National Capital vs. Baltimore metro region when pharmacist questions no questions. Of 11 pharmacy visits completed, 10 said they currently stock, with one clarifying existing only.About 69% may face challenges calling find out can obtain pharmacies. Better patient education more thorough pharmacy-level investigation system workflow barriers could offer solutions.

Language: Английский

---

Understanding the role of community pharmacies in current medication for opioid use disorder care practices

Journal of the American Pharmacists Association, Journal Year: 2022, Volume and Issue: 63(1), P. 261 - 268.e2

Published: Sept. 6, 2022

Language: Английский

---